Article Text

PDF
Randomised controlled trial
Community screening for heart failure: ready for prime time?
  1. Robert Neil Doughty
  1. Department of Medicine and National Institute for Health Innovation, University of Auckland, Auckland, New Zealand
  1. Correspondence to : Professor Robert Neil Doughty, Department of Medicine and National Institute for Health Innovation, University of Auckland, Park Road, Grafton, Auckland, Auckland 1001, New Zealand; r.doughty{at}auckland.ac.nz

Statistics from Altmetric.com

Commentary on: OpenUrlCrossRefPubMedWeb of Science

Context

Heart failure (HF) is a major public health problem, with an increasing prevalence. There is an increasing focus on prevention of HF by improved management of cardiovascular disease and risk factors. Previous studies have demonstrated that brain natriuretic peptide (BNP) is predictive of outcome in the general population1 and among patients with established cardiovascular disease.2 More than half of the population aged over 45 years can be classified as ACC/AHA stage A or B for risk of developing symptomatic HF.3

Methods

This was a pragmatic, prospective randomised controlled trial (RCT) based in the community in Ireland. The study was conducted in the setting of a concurrent community-based cardiovascular …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.